𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome

✍ Scribed by James A. Sloand; Mark A. Shelly; Andrew Feigin; Paul Bernstein; Rebeca D. Monk


Book ID
114466542
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
69 KB
Volume
43
Category
Article
ISSN
0272-6386

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A randomized, double-blind, placebo cont
✍ Ludger Grote; Lena Leissner; Jan Hedner; Jan Ulfberg πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 228 KB πŸ‘ 1 views

## Abstract Iron deficiency may exacerbate symptoms in the Restless Legs Syndrome (RLS). We investigated the effect of intravenous iron sucrose or placebo on symptoms in patients with RLS and mild to moderate iron deficit. Sixty patients with primary RLS (seven males, age 46 (9) years, S‐ferritin ≀

A double-blind randomized crossover tria
✍ Dr. Arthur S. Walters; Wayne A. Hening; Neil Kavey; Sudhansu Chokroverty; Steve πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

A double-blind randomized crossover study of 7.5 mg bromocriptine at bedtime versus placebo was conducted in 30-day phases (with a 2-week washout period between phases) in 6 patients with idiopathic restless legs syndrome. Five patients experienced partial subjective improvement in restlessness and